Longitude Capital Partners III LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-08-11 4:08 pm Purchase |
2023-08-01 | 13D | Inozyme Pharma, Inc. INZY |
Longitude Capital Partners III LLC | 5,841,045 9.900% |
1,666,666 (+39.93%) |
Filing |
| 2022-04-28 4:50 pm Purchase |
2022-04-19 | 13D | Inozyme Pharma, Inc. INZY |
Longitude Capital Partners III LLC | 4,174,379 10.400% |
1,355,000 (+48.06%) |
Filing |
| 2020-08-07 5:21 pm Purchase |
2020-07-28 | 13D | Inozyme Pharma, Inc. INZY |
Longitude Capital Partners III LLC | 2,819,379 12.100% |
2,819,379 (New Position) |
Filing |